Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ho

Showing results (1151-1160 of 1,367) with videos related to

Pageof 137
Sort By:
Bone Marrow Transplantation|July 2, 2013
Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unitN Lehners, P Schnitzler, S Geis, et al.
BMJ Open|May 22, 2019
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocolMaria-Luisa Schubert, Anita Schmitt, Leopold Sellner, et al.
Science (New York, N.Y.)|November 21, 1997
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapyD Finzi, M Hermankova, T Pierson, et al.
Nature Communications|January 3, 2025
Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screeningHengrui Liu, Arie Zask, Farhad Forouhar, et al.
Frontiers in Immunology|January 30, 2018
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia PatientsJean-Marc Hoffmann, Maria-Luisa Schubert, Lei Wang, et al.
Journal of Virology|December 16, 1998
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapyG S Ogg, X Jin, S Bonhoeffer, et al.
Biorxiv : the Preprint Server for Biology|October 20, 2022
A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spikeBernadeta Dadonaite, Katharine H D Crawford, Caelan E Radford, et al.
Biorxiv : the Preprint Server for Biology|August 29, 2022
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvirSho Iketani, Hiroshi Mohri, Bruce Culbertson, et al.
Nature Communications|July 4, 2025
Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2Qian Wang, Yicheng Guo, Ryan G Casner, et al.
Cell Host & Microbe|August 27, 2022
Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sitesSho Iketani, Seo Jung Hong, Jenny Sheng, et al.
Pageof 137

Showing results (1151-1160 of 1,367) with videos related to

Sort By:
Pageof 137
Bone Marrow Transplantation|July 2, 2013
Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unitN Lehners, P Schnitzler, S Geis, et al.
BMJ Open|May 22, 2019
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocolMaria-Luisa Schubert, Anita Schmitt, Leopold Sellner, et al.
Science (New York, N.Y.)|November 21, 1997
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapyD Finzi, M Hermankova, T Pierson, et al.
Nature Communications|January 3, 2025
Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screeningHengrui Liu, Arie Zask, Farhad Forouhar, et al.
Frontiers in Immunology|January 30, 2018
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia PatientsJean-Marc Hoffmann, Maria-Luisa Schubert, Lei Wang, et al.
Journal of Virology|December 16, 1998
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapyG S Ogg, X Jin, S Bonhoeffer, et al.
Biorxiv : the Preprint Server for Biology|October 20, 2022
A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spikeBernadeta Dadonaite, Katharine H D Crawford, Caelan E Radford, et al.
Biorxiv : the Preprint Server for Biology|August 29, 2022
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvirSho Iketani, Hiroshi Mohri, Bruce Culbertson, et al.
Nature Communications|July 4, 2025
Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2Qian Wang, Yicheng Guo, Ryan G Casner, et al.
Cell Host & Microbe|August 27, 2022
Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sitesSho Iketani, Seo Jung Hong, Jenny Sheng, et al.
Pageof 137